Advertisement

Topics

ISTA Pharmaceuticals Company Profile

06:02 EST 13th December 2018 | BioPortfolio

ISTA Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved ophthalmic products for serious conditions of the eye. ISTA has three approved products, Xibrom™ (for the treatment of ocular inflammation following cataract surgery), Istalol® (for the treatment of glaucoma) and Vitrase® (for use as a "spreading agent"). We launched Istalol® during Q3 2004, Vitrase® during Q1 2005 and Xibrom™ during Q2 2005. We have received an approvable letter for Vitrase® (for the treatment of vitreous hemorrhage). We have other prescription products under development, including a tobramycin prednisolone acetate for the treatment of inflammation where a bacterial infection might be present, ecabet sodium, for the treatment of dry eye, and Caprogel® for the treatment of hyphema. In order to further build our pipeline as a specialty pharmaceutical company, we expect to acquire complementary products in ophthalmology, either already marketed or in late-stage development. ISTA has been well financed, and our management team has extensive experience in the development and commercialization of ophthalmic pharmaceuticals.

Location

15295 Alton Parkway
Irvine
California
92618
United States of America

Contact

Phone: (949) 788-6000
Fax: (949) 788-6010


News Articles [315 Associated News Articles listed on BioPortfolio]

Consensus Orthopedics to discuss connected health technology at the ISTA 31st Annual Congress

Lunch symposium featuring TracPatch® wearable technology for <!--LGfEGNT2Lhm-->healthcare October 4, 2018 El Dorado Hills, CA – Consensus Orthopedics, Inc. (“Consensus&...

EOS imaging Showcases hipEOS at the International Society for Technology in Arthroplasty (ISTA) in London

Internationally recognized leaders in total hip arthroplasty (THA) to present the value of EOS along the hip care pathway through 7 podium presentations and 3 posters R...

Deals and M&As this week: Aridis Pharmaceuticals, Xeris Pharmaceuticals, Astellas Pharma

Aridis Pharmaceuticals has raised $26m through an initial public offering of two million shares of its common stock priced at $13...Read More... The post Deals and M&As this week: Aridis Pharmac...

GW Pharmaceuticals plc: GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology

VIENNA, Austria, Aug. 28, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the development and commercialization of cannabinoid prescr...

ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement

ACADIA Pharmaceuticals (NASDAQ:ACAD) and Neuren Pharmaceuticals (ASX:NEU) announced today that they have entered into an exclusive North American License Agreement for the development and commercializ...

Checkmate Pharmaceuticals Appoints Barry Labinger President & CEO

Barry Labinger has joined Checkmate Pharmaceuticals as president and CEO, the Cambridge, MA, company announced Wednesday. Labinger comes to the cancer drug developer from Biothera Pharmaceuticals, whe...

Telix Pharmaceuticals Limited: Telix Pharmaceuticals Acquires Advanced Nuclear Medicine Ingredients (ANMI) SA

MELBOURNE, Australia, BRUSSELS and LIÈGE, Belgium, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) ("Telix", the "Company"), a clinical-stage biopharmaceutical company foc.....

Nuvo Pharmaceuticals to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals

NewsUpon closing of the Proposed Transaction, Nuvo would pay Aralez $110 million in cash,

Drugs and Medications [277 Associated Drugs and Medications listed on BioPortfolio]

Bepreve [Ista Pharmaceuticals, Inc]

These highlights do not include all the information needed to use BEPREVE (bepotastine besilate ophthalmic solution) 1.5% safely and effectively. See full prescribing information for BEPREVE.BEPREVE (...

Bepreve [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% safely and effectively. See full prescribing information for BEPREVE™.BEP...

Bromday [Ista Pharmaceuticals, Inc]

These highlights do not include all the information needed to use Bromday™ (bromfenac ophthalmic solution) 0.09% safely and effectively. See full prescribing information for Bromday. Bromday  (brom...

Xibrom [Ista Pharmaceuticals, Inc]

XIBROM™ (bromfenac ophthalmic solution) 0.09%

Bromday [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use Bromday™ (bromfenac ophthalmic solution) 0.09% safely and effectively. See full prescribing information for Bromday. Bromday  (brom...

PubMed Articles [131 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Effects of pharmaceuticals on microbial communities and activity of soil enzymes in mesocosm-scale constructed wetlands.

Cyperus alternifolius based mesocosm-scale constructed wetland was employed to remove pharmaceuticals. We investigated the microbial community composition using phosphor lipid fatty acids (PFLAs) anal...

Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach.

An extensive use of pharmaceuticals and the widespread practices of their erroneous disposal measures have made these products contaminants of emerging concern (CEC). Especially, active pharmaceutical...

Clinical Trials [229 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1343 Associated Companies listed on BioPortfolio]

ISTA Pharmaceuticals

ISTA Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved ophthalmic products for serious conditions of the eye. ISTA...

ISTA Pharmaceuticals, Inc.

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Cascade TEK

Since 1992, Cascade TEK has provided drying solutions for military, aerospace, medical and automotive industries. Our forced air laboratory and vacuum ovens are made in the USA. C...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

More Information about "ISTA Pharmaceuticals" on BioPortfolio

We have published hundreds of ISTA Pharmaceuticals news stories on BioPortfolio along with dozens of ISTA Pharmaceuticals Clinical Trials and PubMed Articles about ISTA Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ISTA Pharmaceuticals Companies in our database. You can also find out about relevant ISTA Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...


Corporate Database Quicklinks



Searches Linking to this Company Record